Trial Profile
Phase I Single and Multiple Ascending Dose Trial of Intravenous CR 845 in Japanese Patients for the Treatment of Acute Pain and Uremic Pruritus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2014
Price :
$35
*
At a glance
- Drugs Difelikefalin (Primary)
- Indications Acute pain; Pruritus
- Focus Adverse reactions
- Sponsors Maruishi Pharmaceutical
- 28 Aug 2014 New trial record